Enzymotec Ltd. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2017. For the quarter, the company's net revenues were $13,017,000 compared to $11,734,000 a year ago. Operating loss was $2,652,000 compared to operating income of $158,000 a year ago. Loss before taxes on income was $2,415,000 compared to income before taxes on income of $222,000 a year ago. Net loss was $2,305,000 compared to net income of $173,000 a year ago. Basic and diluted loss per share was $0.10 against basic and diluted earnings per share of $0.01 a year ago. Adjusted LBITDA was $753,000 compared to adjusted EBITDA of $1,597,000 a year ago. Non-GAAP net loss was $1,483,000 compared to non-GAAP net income of $821,000 a year ago. Non-GAAP diluted LPS was $0.06 compared to non-GAAP diluted EPS of $0.04 a year ago. For the six months, the company's net revenues were $25,015,000 compared to $25,700,000 a year ago. Operating loss was $2,839,000 compared to operating income of $1,507,000 a year ago. Loss before taxes on income was $2,449,000 compared to income before taxes on income of $1,725,000 a year ago. Net loss was $2,280,000 compared to net income of $1,621,000 a year ago. Basic and diluted loss per share was $0.10 against basic and diluted earnings per share of $0.07 a year ago. Adjusted EBITDA was $732,000 compared to $4,338,000 a year ago. Non-GAAP net loss was $717,000 compared to non-GAAP net income of $2,916,000 a year ago. Non-GAAP diluted LPS was $0.03 compared to non-GAAP diluted EPS of $0.12 a year ago. Net cash provided by operating activities was $3,198,000 compared to $1,896,000 a year ago. Purchase of property, plant and equipment was $2,638,000 compared to $924,000 a year ago.